Mechanistic explanation for platelet contribution to cancer metastasis.
about
Interaction between circulating cancer cells and platelets: clinical implicationRevisiting the hallmarks of cancer.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisCombination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patientsCancer and Thrombosis: The Platelet Perspective.Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer.Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.Do methodological differences account for the current controversy on tissue factor expression in platelets?Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records.Tumor cell intravasation.Hodgkin lymphoma cell lines bind to platelets. Incubation with platelets induces CD15 and P-selectin dependent adhesion of the cell lines to Human Umbilical Vein Endothelial cells (HUVEC)Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.Extracellular purines, purinergic receptors and tumor growth.Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation.Cancer and Thrombotic Risk: The Platelet Paradigm.The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma.Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.Platelet-inspired medicine for tumor therapy.The intersection of protein disulfide isomerase and cancer associated thrombosis.Aspirin acts in esophageal cancer: a brief review.The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile SeizureSulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression
P2860
Q26778920-CF8F76D1-733A-4E3B-AACF-E8FE7F22945BQ33732986-AEDCAB77-DF2B-421F-AABC-CD5B63A9700AQ35739397-657120B4-1D6F-417A-A413-CD948E917B7EQ36562386-F14AACD8-7985-42F9-8986-942A9D61FF08Q36618989-1FDFA7D1-A8BE-4190-87C8-7F2C42BB2855Q37188178-7529517D-3B0A-4BF5-920A-1598F4A6B214Q37558436-536244BE-237C-4B88-A674-7CE7B4B4D0BBQ37687778-3F9AA603-A566-4E3A-9616-1B5CC14552E0Q37708829-8AAA9174-188B-4606-812D-A885C36F70B7Q38712560-27C52305-ED25-42A6-8EDD-A22526707931Q38751476-6B6BCC1D-2B52-4993-ADB1-19ADD300DE93Q38807918-E565592B-6659-4CC6-A727-247F3885584FQ38831508-05C35107-336B-4264-ABF4-02D6988DF120Q38838108-5D86FCA3-6DBB-4EE6-B3C0-8BEC066713F9Q38870205-0A7C160E-D610-41DB-B8C4-7A3B31C2A961Q38891836-2F031E31-CE54-4B45-A28F-160D21DC4BD1Q39417307-0B1A1141-012D-45D2-B7B8-694062F4407FQ42279248-25219C17-8DAD-458E-9C13-89C378A5E02CQ44264785-D4FA2160-0DE9-4A94-A8B5-D95AE4451E72Q47136332-0B8D99AB-FA7F-470F-874C-1057404A2173Q47150770-E63FD9B5-A704-4200-86D8-E39D2CA6B1BAQ48265369-B6624418-3153-4B21-BEDF-196C64B682C5Q48372668-36F41E0D-4C86-443E-9F93-149F01CACF34Q48374992-208DEB70-2AD4-49A1-9A25-F3D11DFBFA4EQ49234113-33D9DD79-7DD5-4949-AF27-ABC9B38327DEQ52716147-846F42A7-8893-462D-B877-F51182974DCDQ55375453-E670CDB4-5241-4D26-BA33-D3264FEB8201Q57477149-03659F4C-E1BD-4D26-98D0-9D783C2C9FD4Q58605865-4E41BB97-EA8C-4ADA-A5AD-F78BB57A339D
P2860
Mechanistic explanation for platelet contribution to cancer metastasis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanistic explanation for platelet contribution to cancer metastasis.
@en
type
label
Mechanistic explanation for platelet contribution to cancer metastasis.
@en
prefLabel
Mechanistic explanation for platelet contribution to cancer metastasis.
@en
P1433
P1476
Mechanistic explanation for platelet contribution to cancer metastasis.
@en
P2093
Bernhard Nieswandt
Sebastian Dütting
P304
P356
10.1016/S0049-3848(14)50025-4
P478
133 Suppl 2
P577
2014-05-01T00:00:00Z